Prevalence and pattern of PCOS in women presenting with acne, a hospital based prospective observational study

Raja Shareef A., P. V. S. Prasad, P. K. Kaviarasan


Background: Acne is one of the most common dermatological conditions encountered in day to day practice. Many recent studies have reported a strong association between acne and underlying systemic endocrine disorders, more particularly Poly cystic ovarian syndrome. But there is scarcity of literature on the subjects in Indian population. Hence the present study was conducted with an objective of studying the association between acne and polycystic ovarian syndrome, in women presenting with adult onset acne to a tertiary care teaching hospital.

Methods: A prospective observational study was carried out in department of dermatology, Dhananalakshmi Srinivasan medical college and hospital, Permabalur from January 2016 to August 2017. The study population included women above 18 years of age clinically diagnosed with acne vulgaris. The presence of polycystic ovarian syndrome was assessed using Rotterdam criteria.

Results: The final analysis had included 100 women with acne. The most common type of lesion observed was comedone in 91% of women. The other most common lesions were papule seen in 73%, pustule in 35% of women. The proportion with grade I, Grade II and grade III acne was 58%, 29% and 13% respectively. The prevalence of PCOS was 30% (95% CI 21.89% to 39.58%). PCOS had shown no statistically significant association with age, marital status and regularity of menstrual cycle. The factors which have shown statistically significant association were higher BMI, presence of Hirsutism and higher waist circumference.

Conclusions: PCOS is highly prevalent among women with acne. Presence of hirsutism, obesity are strong risk factors for PCOS.


Acne, PCOS

Full Text:



Aydemir EH. Acne vulgaris. Turk Pediatri Ars. 2014;49(1):13-6.

Zaidi Z. Acne vulgaris-an update on pathophysiology and treatment. J Pak Med Assoc. 2009;59(9):635-7.

Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014;32(3):389-96.

Ozdemir S, Ozdemir M, Gorkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199-204.

Alan S, Cenesizoglu E. Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Med J. 2014;35(8):886-9.

Ianosi S, Ianosi G, Neagoe D, Ionescu O, Zlatian O, Docea AO, et al. Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women. Mol Med Rep. 2016;14(6):5501-6.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.

IBMCorp. IBM SPSS Statistics for Windows. 21.0 ed. Armonk, NY: IBM Corp; 2012.

Betti R, Bencini PL, Lodi A, Urbani CE, Chiarelli G, Crosti C. Incidence of polycystic ovaries in patients with late-onset or persistent acne: hormonal reports. Dermatologica. 1990;181(2):109-11.

Kelekci KH, Kelekci S, Incki K, Ozdemir O, Yilmaz B. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Int J Dermatol. 2010;49(7):775-9.

Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol. 2010;9(2):142-8.

Abdullah Z, Masood Q, Hassan I, Kirmani O. Hormonal profile and polycystic ovaries in women with acne vulgaris. Ind J Dermatol Venereol Leprol. 2013;79(3):422-4.

Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings. J Am Acad Dermatol. 2016;20(4):194-8.

Falsetti L, Gambera A, Andrico S, Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecol Endocrinol. 2002;16(4):275-84.

Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol. 2007;8(4):201-19.